Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC
This study determine the maximal tolerate dose
Colorectal Cancer
DRUG: Oxaliplatin|DRUG: LV5FU or Folfiri|DRUG: Oxycodone
Maximum tolerated dose, To determine:

- Maximum tolerated dose (MTD),, through study completion, an average of 3 year
Area Under the Curve (AUC), To evaluate Long term pharmacokinetic profile of associated targeted agents in tumoral tissue, through study completion, an average of 3 year
This study determine the maximal tolerate dose for the patient treated by intraperitoneal chemotherapy in neoadjuvant treatment of peritoneal carcinomatosis of colorectal origin